Analysis of maternal and neonatal factors that influence the nucleated and CD34+ cell yield for cord blood banking

Transfusion

Volumn 44, Issue 2, 2004, Pages 262-267

  Nakagawa, Ryuji ^a   Watanabe, Tsutomu ^b   Kawano, Yoshifumi ^b   Kanai, Sachiyo ^b   Suzuya, Hiroko ^b   Kaneko, Michiya ^b   Watanabe, Hiroyoshi ^b   Okamoto, Yasuhiro ^b   Kuroda, Yasuhiro ^b   Nakayama, Takayoshi ^b  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ADULT; ARTICLE; BLOOD BANK; BLOOD STORAGE; CELL COUNT; COLONY FORMING UNIT GM; CONCENTRATION RESPONSE; CORRELATION ANALYSIS; FEMALE; FETOMATERNAL TRANSFUSION; GESTATIONAL AGE; HUMAN; MATERNAL AGE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEWBORN; NORMAL HUMAN; PLACENTA; PREDICTION; T LYMPHOCYTE SUBPOPULATION; TOTAL NUCLEATED CELL; UMBILICAL CORD BLOOD;

AGE FACTORS; ANTIGENS, CD34; BLOOD BANKS; CELL NUCLEUS; FEMALE; FETAL BLOOD; GESTATIONAL AGE; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MATERNAL AGE; PLACENTA; PREDICTIVE VALUE OF TESTS; PREGNANCY; REGRESSION ANALYSIS; SEX FACTORS;

EID: 10744227586     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2004.00645.x     Document Type: Article

References (22)

1. Gluckman E, Broxmeyer HE, Auerbach AD, et al. Hematopoietic reconstitution in a patient with a Fanconi's anemia by means of umbilical cord blood from a HLA identical sibling. N Engl J Med 1989;321:1174-8.
2. Broxmeyer H, Douglas G, Hangoc G, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A 1989;86:3828-32.
3. Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996;353:157-66.
4. Rubinstein P, Dobrila L, Rosenfield RE, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A 1995;92:10119-12.
5. Rocha V, Wagner JE, Sobocinski KA, et al. Graft-versus-host disease in children who have received a cord blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 2000;342:1846-54.
6. Cairo MS, Wagner JE. Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood 1997;90:4665-78.
7. Sanz GF, Saavedra S, Planelles D, et al. Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood 2001;98:2332-8.
8. Shpall EJ, Quinones R, Giller R, et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 2002;8:368-76.
9. Barker JN, Weisdorf DJ, Wagner JE. Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors (letter). N Engl J Med 2001;344:1870-1.
10. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental blood transplants from unrelated donors. N Engl J Med 1998;339:1565-77.
11. Fraser JK, Cairo MS, Wagner EL, et al. Cord Blood Transplantation Study (COBLT): cord blood bank standard operating procedures. J Hematother 1998;7:521-61.
12. Sirchia G, Rebulla P, Tibaldi S, Lecchi L. Cost of umbilical cord blood units released for transplantation. Transfusion 1999;39:645-50.
13. Locatelli F, Rocha V, Chastang C, et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group. Blood 1999;93:3662-71.
14. Ballen KK, Wilson M, Wuu J, et al. Bigger is better: maternal and neonatal predictors of hematopoietic potential of umbilical cord blood units. Bone Marrow Transplant 2001;27:7-14.
15. Donaldson C, Armitage WJ, Laundy V, et al. Impact of obstetric factors on cord blood donation for transplantation. Br J Haematol 1999;106:128-32.
16. Lasky LC, Lane TA, Miller JP, et al. In utero or ex utero cord blood collection: which is better? Transfusion 2002;42:1261-7.
17. Li K, Yau FW, Fok TF, et al. Haematopoietic stem and progenitor cells in human term and preterm neonatal blood. Vox Sang 2001;80:162-9.
18. Shlebak AA, Roberts IA, Stevens TA, et al. The impact of antenatal and perinatal variables in cord blood hematopoietic stem/progenitor cell yield available for transplantation. Br J Haematol 1998;103:1167-71.
19. Lu L, Xiao M, Shen R-N, et al. Enrichment, characterization, and responsiveness of single primitive CD34 human umbilical cord blood hematopoietic progenitors with high proliferative and replating potential. Blood 1993;81:41-8.
20. Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant disease: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002;100:1611-18.
21. Haneline LS, Marshall KP, Clapp DW. The highest concentration of primitive hematopoietic progenitor cells in cord blood is found in extremely premature infants. Pediatr Res 1996;39:820-5.
22. Wyrsch A, dalle Carbonare V, Jansen W, et al. Umbilical cord blood from preterm human fetuses is rich in committed and primitive hematopoietic progenitors with high proliferative and self-renewal capacity. Exp Hematol 1999;27:1338-45.